| |
|
|
Phospholipids
|
Using the latest synthetic and purification technologies, NOF manufactures and supplies highly purified phospholipid derivatives (COATSOME Series) suitable for lipid emulsion formulations and liposome formulations which are extensively used for pharmaceuticals and cosmetics. Concerning the phospholipids for pharmaceuticals and cosmetics, various kinds and grades of such phospholipids are readily available. In addtion, we can respond to requests from our customers by tailor-made synthesis of any phospholipids with the desired structures. For the benefit of easy liposome binding of the drugs at the customers' facilities, NOF provides empty liposome kits, liposomal formulations and liposomal drugs delivery systems. When PEGylated phospholipids are used as liposomes, the aqueous layer can coat the liposome surface, whereby the liposome preparations encapsulating drugs within them can be stably dispersed in aqueous solutions.
Online shopping is available the following products.
|
|
|

What's New
DDS
2010/07/26 Program for Liposome Conference in Vancouver, Aug 4-8, 2010
PDF
2010/07/08
NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010
2010/06/30 NOF release New Activated PEG
2010/05/21 NOF AMERICA CORPORATION opened a new office in California
On May 7, NOF AMERICA CORPORATION, a wholly owned subsidiary of NOF,
opened a new office in California to further enhance its sales
activities in the North American market
Post Address: 2102 Business Center Drive, Suite 130 Irvine, CA 92612, USA
2010/03/11 NOF partners with ENZON on PEG derivatives
PDF
2010/01/07 NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery
PDF
|